95 related articles for article (PubMed ID: 23352111)
1. Retargeting of regulatory T cells to surface-inducible autoantigen La/SS-B.
Koristka S; Cartellieri M; Arndt C; Bippes CC; Feldmann A; Michalk I; Wiefel K; Stamova S; Schmitz M; Ehninger G; Bornhäuser M; Bachmann M
J Autoimmun; 2013 May; 42():105-16. PubMed ID: 23352111
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel single-chain bispecific antibody for retargeting of T cells to tumor cells via the TCR co-receptor CD8.
Michalk I; Feldmann A; Koristka S; Arndt C; Cartellieri M; Ehninger A; Ehninger G; Bachmann MP
PLoS One; 2014; 9(4):e95517. PubMed ID: 24751697
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Fc gamma receptor mediated T-cell activation by two purified CD3 x CD19 bispecific monoclonal antibodies with hybrid Fc domains.
Haagen IA; Geerars AJ; Bast EJ; de Gast GC; van de Winkel JG; de Lau WB
Ther Immunol; 1994 Oct; 1(5):279-87. PubMed ID: 7584502
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of dendritic cells and anti-CD3/CD28 expanded regulatory T cells for application in transplantation.
Zeng M; Guinet E; Nouri-Shirazi M
Transpl Immunol; 2009 Dec; 22(1-2):82-92. PubMed ID: 19635560
[TBL] [Abstract][Full Text] [Related]
5. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
6. Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells.
Feldmann A; Arndt C; Töpfer K; Stamova S; Krone F; Cartellieri M; Koristka S; Michalk I; Lindemann D; Schmitz M; Temme A; Bornhäuser M; Ehninger G; Bachmann M
J Immunol; 2012 Sep; 189(6):3249-59. PubMed ID: 22875801
[TBL] [Abstract][Full Text] [Related]
7. Direct antigen presentation by DC shapes the functional CD8(+) T-cell repertoire against the nuclear self-antigen La-SSB.
Keech CL; Pang KC; McCluskey J; Chen W
Eur J Immunol; 2010 Feb; 40(2):330-8. PubMed ID: 19950171
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the mouse autoantigen La (SS-B). Identification of conserved RNA-binding motifs, a putative ATP binding site and reactivity of recombinant protein with poly(U) and human autoantibodies.
Topfer F; Gordon T; McCluskey J
J Immunol; 1993 Apr; 150(7):3091-100. PubMed ID: 8454877
[TBL] [Abstract][Full Text] [Related]
9. T cell reactivity to Sjögren's syndrome related antigen La(SSB).
Helsloot J; Sturgess A
J Rheumatol; 1997 Dec; 24(12):2340-7. PubMed ID: 9415639
[TBL] [Abstract][Full Text] [Related]
10. Activation of T cell cytotoxicity against autologous common acute lymphoblastic leukemia (cALL) blasts by CD3xCD19 bispecific antibody.
Csóka M; Strauss G; Debatin KM; Moldenhauer G
Leukemia; 1996 Nov; 10(11):1765-72. PubMed ID: 8892680
[TBL] [Abstract][Full Text] [Related]
11. Bispecific antibody-mediated cytotoxicity by CD4+ and CD8(+)-activated T cells generated from leukemia patients after allogeneic bone marrow transplantation.
Hattori K; Tsukamoto H; Ohta S; Yabe M; Yabe H; Kato S; Takakura I; Ueda R; Habu S; Nishimura T
Bone Marrow Transplant; 1995 Feb; 15(2):193-8. PubMed ID: 7773208
[TBL] [Abstract][Full Text] [Related]
12. Tumor-specific crosslinking of GITR as costimulation for immunotherapy.
Burckhart T; Thiel M; Nishikawa H; Wüest T; Müller D; Zippelius A; Ritter G; Old L; Shiku H; Renner C
J Immunother; 2010; 33(9):925-34. PubMed ID: 20948444
[TBL] [Abstract][Full Text] [Related]
13. Feedback loop of immune regulation by CD4+CD25+ Treg.
Jung YJ; Seoh JY
Immunobiology; 2009; 214(4):291-302. PubMed ID: 19327546
[TBL] [Abstract][Full Text] [Related]
14. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.
Dinh TN; Kyaw TS; Kanellakis P; To K; Tipping P; Toh BH; Bobik A; Agrotis A
Circulation; 2012 Sep; 126(10):1256-66. PubMed ID: 22851544
[TBL] [Abstract][Full Text] [Related]
15. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F
Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769
[TBL] [Abstract][Full Text] [Related]
16. Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells.
De Lau WB; Boom SE; Heije K; Griffioen AW; Braakman E; Bolhuis RL; Tax WJ; Clevers H; Bast BJ
J Immunol; 1992 Sep; 149(6):1840-6. PubMed ID: 1387662
[TBL] [Abstract][Full Text] [Related]
17. Trispecific F(ab')3 derivatives that use cooperative signaling via the TCR/CD3 complex and CD2 to activate and redirect resting cytotoxic T cells.
Tutt A; Stevenson GT; Glennie MJ
J Immunol; 1991 Jul; 147(1):60-9. PubMed ID: 1675655
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
19. Induction of autoimmunity by multivalent immunodominant and subdominant T cell determinants of La (SS-B).
Farris AD; Brown L; Reynolds P; Harley JB; James JA; Scofield RH; McCluskey J; Gordon TP
J Immunol; 1999 Mar; 162(5):3079-87. PubMed ID: 10072561
[TBL] [Abstract][Full Text] [Related]
20. Identification of a human-specific epitope in a conserved region of the La/SS-B autoantigen.
Weng YM; McNeilage J; Topfer F; McCluskey J; Gordon T
J Clin Invest; 1993 Aug; 92(2):1104-8. PubMed ID: 7688758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
